Reem Khalid Almanea

Reem Khalid Almanea

Auto-generated profile, based on publicly available information

Reem Khalid Almanea

Department of Family and Polyclinic, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
FAFahad Aleidan
Fahad Aleidan
RAReem K AlManea
Reem K AlManea
AAAlyah T AlMoneef
Alyah T AlMoneef
NSNada A Shalash
Nada A Shalash
NANorah A AlRajhi
Norah A AlRajhi
KAKhadega A Abuelgasim
Khadega A Abuelgasim
Background: Little is written about recurrence and mortality rates after a first episode of venous thromboembolism (VTE) among Saudi population. Aim: Determine incidence rates and assess predictors of recurrence and mortality following the first VTE event. Patients and Methods: A total of 1124 patients aged ≥ 18 years with symptomatic VTE confirmed by imaging tests were evaluated. The incidence of VTE recurrence and mortality were assessed. The association between patient characteristics, and VTE recurrence and mortality was explored by estimating the hazard ratio (HR) and 95% confidence interval (CI). The difference between cancer-related, provoked and unprovoked VTE in terms of recurrence and mortality was explored using Kaplan–Meier curves. Results: The annual incidence rate of the first VTE was 1.7 per 1000 patients. Of 1124 patients with first VTE, 214 (19%) developed recurrent VTE, and 192 (17%) died with overall incidence rates of 15.8 per 100 person-years (95% CI, 13.8– 18.0) and 10.0 per 100 person-years (95% CI, 8.7– 11.5). Intensive care unit (ICU) admission (HR, 2.15; 95% CI, 1.67– 3.10), presence of active cancer (HR, 2.97; 95% CI, 1.87– 3.95), immobilization (HR, 2.52; 95% CI, 1.79– 3.67), infection (HR, 2.32; 95% CI, 1.94– 3.45), and pulmonary embolism ± deep venous thrombosis (HR, 2.22; 95% CI, 1.56– 3.16) were found to be independent predictors of recurrent VTE. Recurrence carries a high hazard of mortality (HR, 5.21; 95% CI, 3.61– 7.51). The estimated median time to VTE recurrence was lower in cancer-related VTE (18.7 months) compared with provoked (29.0 months) and unprovoked VTE (28.4 months). The estimated survival median time was lower in cancer-related VTE (21.8 months) compared with provoked (30.5 months) and unprovoked VTE (29.8 months). Conclusion: Immobilization and presence of active cancer, infection, and PE ± DVT were significant predictors of recurrent VTE. Patients who developed recurrent VTE had a 5.2-fold higher hazard of mortality compared with patients with no VTE recurrence.

1 April 2025 in AME Case Reports
Verified
Journal Article
Open access
PDF file
MAMansour Ibrahim Alrasheed
Mansour Ibrahim Alrasheed
RAReem Khalid Almanea
Reem Khalid Almanea
BHBashayr Mohammed Hijaz
Bashayr Mohammed Hijaz
MRMuhammad Riazuddin
Muhammad Riazuddin
Background: Hyponatremia, a prevalent electrolyte imbalance with varying degrees of severity, can lead to mild to severe complications. Trimethoprim-sulfamethoxazole (TMP-SMX) and spironolactone are two frequently administered medications; regrettably, most healthcare professionals are not aware that these medications might cause hyponatremia. Concurrently, the two drugs have a high chance of medication interactions that raise the risk of hyponatremia, hyperkalemia, and death overall. TMP-SMX is implicated in causing hyponatremia through diverse mechanisms, such as inhibiting the renal tubular epithelial enzyme carbonic anhydrase. Structurally akin to the potassium-sparing diuretic amiloride, TMP-SMX is linked to hyperkalemia and hyponatremia by obstructing epithelial sodium channels in the distal nephron. Moreover, TMP-SMX may enhance antidiuretic hormone (ADH) release, exacerbating the imbalance. Case Description: This is a case of a 76-year-old man with a medical history including hypertension, type II diabetes, coronary artery disease, and dyslipidemia. This case highlights an elderly patient treated with TMP-SMX for a soft tissue wound infection, which resulted in severe hyponatremia. Conclusions: Timely identification and careful monitoring of TMP-SMX-induced hyponatremia enabled the correction of sodium levels without severe complications. Thus, this report underscores the importance of vigilant monitoring and prompt identification of hyponatremia in patients undergoing TMP-SMX treatment. Further research is warranted due to limited data on the precise mechanisms of TMP-SMX-induced hyponatremia.